We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$77M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Financials 13.66%
2 Consumer Discretionary 12.98%
3 Consumer Staples 8.41%
4 Energy 8.01%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
376
Palo Alto Networks
PANW
$265B
$59.9K 0.01%
1,764
+1,194
+209% +$44.7K
AIG icon
377
American International
AIG
$41.8B
$58.2K 0.01%
+1,093
New +$54.5K
BA icon
378
PUT
Boeing
BA
$175B
$58.1K 0.01%
+200
New +$72.9K
PEP icon
379
PUT
PepsiCo
PEP
$191B
$57K 0.01%
+700
New +$89.7K
ADBE icon
380
Adobe
ADBE
$98.5B
$56.6K 0.01%
+192
New +$53.3K
AMD icon
381
Advanced Micro Devices
AMD
$791B
$55.8K 0.01%
+1,838
New +$52.4K
RY icon
382
Royal Bank of Canada
RY
$292B
$55.2K 0.01%
695
CORT icon
383
Corcept Therapeutics
CORT
$12.7B
$55.2K 0.01%
+4,953
New +$55.2K
LIN icon
384
PUT
Linde
LIN
$235B
$55.1K 0.01%
410
-1,283
-76% -$240K
ALL icon
385
Allstate
ALL
$68.3B
$54.8K 0.01%
+539
New +$52.7K
CAT icon
386
Caterpillar
CAT
$373B
$53.8K 0.01%
+395
New +$52.2K
ORCL icon
387
Oracle
ORCL
$367B
$52.2K 0.01%
916
+66
+8% +$3.57K
APA icon
388
PUT
APA Corp
APA
$12.8B
$51.4K 0.01%
+2,500
New +$77.7K
CNI icon
389
Canadian National Railway
CNI
$76.9B
$50.5K 0.01%
545
AUTL
390
Autolus Therapeutics
AUTL
$407M
$49.7K 0.01%
+3,088
New +$69.1K
UPS icon
391
United Parcel Service
UPS
$89.5B
$48.3K 0.01%
468
-25
-5% -$2.6K
GS icon
392
Goldman Sachs
GS
$302B
$48.1K 0.01%
235
-259
-52% -$51.3K
BTE icon
393
Baytex Energy
BTE
$3.04B
$47.7K 0.01%
30,772
AABA
394
DELISTED
Altaba Inc
AABA
$46K 0.01%
+663
New +$46.4K
LUMN icon
395
Lumen
LUMN
$6.76B
$45.2K 0.01%
3,843
-213
-5% -$2.4K
GIS icon
396
General Mills
GIS
$19.4B
$45.2K 0.01%
860
+250
+41% +$12.9K
TTWO icon
397
Take-Two Interactive
TTWO
$46.3B
$44.7K 0.01%
394
BBD icon
398
Banco Bradesco
BBD
$37.9B
$42.9K 0.01%
+5,822
New +$39.8K
CBRE icon
399
CBRE Group
CBRE
$43.8B
$41.5K 0.01%
809
EWJ icon
400
iShares MSCI Japan ETF
EWJ
$22.1B
$40.4K 0.01%
740
+251
+51% +$13.7K

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.